SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of Commencement of a Class Action...
August 26 2016 - 9:44AM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Emergent Biosolutions Inc. (“Emergent
Biosolutions” or the “Company”) (NYSE:EBS) between January 11,
2016 and June 21, 2016.
You are hereby notified that a class action has been
commenced in the USDC for the District of Maryland. If you
purchased or otherwise acquired Emergent Biosolutions securities
between January 11, 2016 and June 21, 2016, your rights may be
affected by this action. To get more information go to:
http://www.zlk.com/pslra/emergent-biosolutions
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
The complaint alleges that defendants issued materially false
and misleading information regarding the Company’s business and
financial prospects, particularly in relation to potential contract
renewals and demand from the U.S. government for its anthrax
vaccine BioThrax. The complaint further alleges that these positive
statements caused the stock to trade at artificially inflated
prices, allowing insiders to sell their shares at these inflated
prices.
On June 22, 2016, before the open of trading, Emergent
Biosolutions announced that the U.S. government had notified the
Company it would only be purchasing 29.4 million doses of the
vaccine over the following five years—an amount approximately one
third less than the original contract. In addition, the Company
disclosed that the government was seeking other anthrax vaccines,
and that it was putting its supply bid out to other companies.
If you suffered a loss in Emergent Biosolutions you have
until September 19, 2016 to
request that the Court appoint you as lead plaintiff. Your ability
to share in any recovery doesn’t require that you serve as a lead
plaintiff.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation, and have recovered
hundreds of millions of dollars for aggrieved shareholders.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160826005349/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq., 212-363-7500Toll
Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024